Ecolab Inc has reported second quarter net sales of US$3.26 billion, a rise of 13 per cent from $3.162 billion one year earlier.
Ecolab’s second quarter profit dipped slightly from $310 million, or $1.08 per share, one year ago to $308 million, or $1.08 per share.
Sales in the company’s global institutional and specialty division jumped 18 per cent to $1.1 billion while its global industrial division increased sales 13 per cent to $1.7 billion.
Ecolab’s global health care and life sciences division saw sales soar 37 per cent from $292 million to $400 million in the second quarter of 2022.
Christophe Beck, Ecolab’s chairman and CEO, said, the company now enters the second half of 2022 in a strong position.
“With the global energy surcharge mechanism implemented, total pricing is expected to accelerate further to keep us ahead of inflation, resulting in easing year-over-year margin pressure going forward,” said Beck.
“As we also prepare for a potentially more challenging macroeconomic environment, our primary focus will now shift to new business development to support our strong topline momentum.”
Comment below to have your say on this story.
If you have a news story or tip-off, get in touch at info@incleanmag.com.au
Sign up to INCLEAN’s newsletter.
